Global Circulating Tumor Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Published On: Feb 2019

Format: PDF

Publisher: XYZ Research

Pages: 133

Report ID: 225104

In this report, the global Circulating Tumor Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Circulating Tumor Cells in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Circulating Tumor Cells market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Janssen
Qiagen(Adnagen)
Acousys Biodevices, Inc
ApoCell
Advanced Cell Diagnostics
Fluxion Biosciences
Biocept
Fluidigm
Epic Sciences
Clearbridge Biomedics
Cynvenio
CytoTrack
ScreenCell
Creatv Microtech
Aviva Biosciences
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
CTC Enrichment
CTC Detection
CTC Analysis
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Circulating Tumor Cells for each application, including
Prostate Cancer
Breast Cancer
Colorectal Cancer
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Circulating Tumor Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Market Overview
1.1 Circulating Tumor Cells Introduction
1.2 Market Analysis by Type
1.2.1 CTC Enrichment
1.2.2 CTC Detection
1.2.3 CTC Analysis
1.3 Market Analysis by Applications
1.3.1 Prostate Cancer
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Others
1.4 New Project SWOT Analysis of Circulating Tumor Cells
1.5 Industry News Analysis of Circulating Tumor Cells

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Circulating Tumor Cells
2.2 Raw Material Analysis of Circulating Tumor Cells
2.2.1 Raw Material A Market Analysis
2.2.2 Raw Material B Market Analysis
2.2.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Circulating Tumor Cells
2.4 Other Costs Analysis of Circulating Tumor Cells
2.5 Manufacturing Cost Structure Analysis of Circulating Tumor Cells
2.6 Manufacturing Process Analysis of Circulating Tumor Cells
2.7 Raw Materials Sources of Circulating Tumor Cells Major Manufacturers in 2017
2.8 Downstream Buyers of Circulating Tumor Cells

3 Global Circulating Tumor Cells Players Profiles and Sales Data
3.1 Janssen
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Circulating Tumor Cells Product Category, Application and Specification
3.1.2.1 CTC Enrichment
3.1.2.2 CTC Detection
3.1.2.3 CTC Analysis
3.1.3 Janssen Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 Janssen Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 Janssen Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.2 Qiagen(Adnagen)
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Circulating Tumor Cells Product Category, Application and Specification
3.2.2.1 CTC Enrichment
3.2.2.2 CTC Detection
3.2.2.3 CTC Analysis
3.2.3 Qiagen(Adnagen) Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Qiagen(Adnagen) Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Qiagen(Adnagen) Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.3 Acousys Biodevices, Inc
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Circulating Tumor Cells Product Category, Application and Specification
3.3.2.1 CTC Enrichment
3.3.2.2 CTC Detection
3.3.2.3 CTC Analysis
3.3.3 Acousys Biodevices, Inc Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Acousys Biodevices, Inc Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Acousys Biodevices, Inc Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.4 ApoCell
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Circulating Tumor Cells Product Category, Application and Specification
3.4.2.1 CTC Enrichment
3.4.2.2 CTC Detection
3.4.2.3 CTC Analysis
3.4.3 ApoCell Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 ApoCell Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 ApoCell Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.5 Advanced Cell Diagnostics
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Circulating Tumor Cells Product Category, Application and Specification
3.5.2.1 CTC Enrichment
3.5.2.2 CTC Detection
3.5.2.3 CTC Analysis
3.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Advanced Cell Diagnostics Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Advanced Cell Diagnostics Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.6 Fluxion Biosciences
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Circulating Tumor Cells Product Category, Application and Specification
3.6.2.1 CTC Enrichment
3.6.2.2 CTC Detection
3.6.2.3 CTC Analysis
3.6.3 Fluxion Biosciences Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Fluxion Biosciences Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Fluxion Biosciences Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.7 Biocept
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Circulating Tumor Cells Product Category, Application and Specification
3.7.2.1 CTC Enrichment
3.7.2.2 CTC Detection
3.7.2.3 CTC Analysis
3.7.3 Biocept Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Biocept Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 Biocept Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.8 Fluidigm
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Circulating Tumor Cells Product Category, Application and Specification
3.8.2.1 CTC Enrichment
3.8.2.2 CTC Detection
3.8.2.3 CTC Analysis
3.8.3 Fluidigm Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Fluidigm Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Fluidigm Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.9 Epic Sciences
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Circulating Tumor Cells Product Category, Application and Specification
3.9.2.1 CTC Enrichment
3.9.2.2 CTC Detection
3.9.2.3 CTC Analysis
3.9.3 Epic Sciences Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Epic Sciences Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Epic Sciences Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.10 Clearbridge Biomedics
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Circulating Tumor Cells Product Category, Application and Specification
3.10.2.1 CTC Enrichment
3.10.2.2 CTC Detection
3.10.2.3 CTC Analysis
3.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 Clearbridge Biomedics Different Types of Circulating Tumor Cells Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 Clearbridge Biomedics Circulating Tumor Cells Volume in Different Applications and Its Application Share
3.11 Cynvenio
3.12 CytoTrack
3.13 ScreenCell
3.14 Creatv Microtech
3.15 Aviva Biosciences

4 Global Circulating Tumor Cells Market Competition by Manufacturers
4.1 Global Circulating Tumor Cells Sales and Share by Manufacturers (2012-2017)
4.2 Global Circulating Tumor Cells Revenue (Million USD) and Share (%) by Manufacturers (2012-2017)
4.3 Market Concentration Rate
4.3.1 Top 3 Circulating Tumor Cells Manufacturer Market Share
4.3.2 Top 6 Circulating Tumor Cells Manufacturer Market Share
4.4 Market Competition Trend

5 Global Circulating Tumor Cells Market Analysis by Regions
5.1 Global Circulating Tumor Cells Sales, Revenue and Market Share by Regions
5.1.1 Global Circulating Tumor Cells Sales by Regions (2012-2017)
5.1.2 Global Circulating Tumor Cells Revenue by Regions (2012-2017)
5.2 North America Circulating Tumor Cells Sales and Growth Rate (2012-2017)
5.3 Europe Circulating Tumor Cells Sales and Growth Rate (2012-2017)
5.4 Asia-Pacific Circulating Tumor Cells Sales and Growth Rate (2012-2017)
5.5 South America Circulating Tumor Cells Sales and Growth Rate (2012-2017)
5.6 Middle East and Africa Circulating Tumor Cells Sales and Growth Rate (2012-2017)

6 North America Circulating Tumor Cells by Countries
6.1 North America Circulating Tumor Cells Sales, Revenue and Market Share by Countries
6.1.1 North America Circulating Tumor Cells Sales by Countries (2012-2017)
6.1.2 North America Circulating Tumor Cells Revenue by Countries (2012-2017)
6.2 United States Circulating Tumor Cells Sales and Growth Rate (2012-2017)
6.3 Canada Circulating Tumor Cells Sales and Growth Rate (2012-2017)
6.4 Mexico Circulating Tumor Cells Sales and Growth Rate (2012-2017)

7 Europe Circulating Tumor Cells by Countries
7.1 North America Circulating Tumor Cells Sales, Revenue and Market Share by Countries
7.1.1 Europe Circulating Tumor Cells Sales by Countries (2012-2017)
7.1.2 Europe Circulating Tumor Cells Sales by Countries (2012-2017)
7.2 Germany Circulating Tumor Cells Sales and Growth Rate (2012-2017)
7.3 France Circulating Tumor Cells Sales and Growth Rate (2012-2017)
7.4 UK Circulating Tumor Cells Sales and Growth Rate (2012-2017)
7.5 Russia Circulating Tumor Cells Sales and Growth Rate (2012-2017)
7.6 Italy Circulating Tumor Cells Sales and Growth Rate (2012-2017)

8 Asia-Pacific Circulating Tumor Cells by Countries
8.1 Asia-Pacific Circulating Tumor Cells Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Circulating Tumor Cells Sales by Countries (2012-2017)
8.1.2 Asia-Pacific Circulating Tumor Cells Sales by Countries (2012-2017)
8.2 China Circulating Tumor Cells Sales and Growth Rate (2012-2017)
8.3 Japan Circulating Tumor Cells Sales and Growth Rate (2012-2017)
8.4 Korea Circulating Tumor Cells Sales and Growth Rate (2012-2017)
8.5 India Circulating Tumor Cells Sales and Growth Rate (2012-2017)
8.6 Circulating Tumor Cells Sales and Growth Rate (2012-2017)

9 South America Circulating Tumor Cells by Countries
9.1 South America Circulating Tumor Cells Sales, Revenue and Market Share by Countries
9.1.1 South America Circulating Tumor Cells Sales by Countries (2012-2017)
9.1.2 South America Circulating Tumor Cells Sales by Countries (2012-2017)
9.2 Brazil Circulating Tumor Cells Sales and Growth Rate (2012-2017)
9.3 Argentina Circulating Tumor Cells Sales and Growth Rate (2012-2017)
9.4 Columbia Circulating Tumor Cells Sales and Growth Rate (2012-2017)

10 Middle East and Africa Circulating Tumor Cells by Countries
10.1 Middle East and Africa Circulating Tumor Cells Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Circulating Tumor Cells Sales by Countries (2012-2017)
10.1.2 Middle East and Africa Circulating Tumor Cells Sales by Countries (2012-2017)
10.2 Circulating Tumor Cells Sales and Growth Rate (2012-2017)
10.3 UAE Circulating Tumor Cells Sales and Growth Rate (2012-2017)
10.4 Egypt Circulating Tumor Cells Sales and Growth Rate (2012-2017)
10.5 Nigeria Circulating Tumor Cells Sales and Growth Rate (2012-2017)
10.6 South Africa Circulating Tumor Cells Sales and Growth Rate (2012-2017)

11 Global Circulating Tumor Cells Market Segment by Type
11.1 Global Circulating Tumor Cells Sales, Revenue and Market Share by Type (2012-2017)
11.1.1 Global Circulating Tumor Cells Sales and Market Share by Type (2012-2017)
11.1.2 Global Circulating Tumor Cells Revenue and Market Share by Type (2012-2017)
11.2 CTC Enrichment Sales Growth Rate and Price
11.2.1 Global CTC Enrichment Sales Growth Rate (2012-2017)
11.2.2 Global CTC Enrichment Price (2012-2017)
11.3 CTC Detection Sales Growth Rate and Price
11.3.1 Global CTC Detection Sales Growth Rate (2012-2017)
11.3.2 Global CTC Detection Price (2012-2017)
11.4 CTC Analysis Sales Growth Rate and Price
11.4.1 Global CTC Analysis Sales Growth Rate (2012-2017)
11.4.2 Global CTC Analysis Price (2012-2017)
11.5 Sales Growth Rate and Price
11.5.1 Global Sales Growth Rate (2012-2017)
11.5.2 Global Price (2012-2017)
11.6 Sales Growth Rate and Price
11.6.1 Global Sales Growth Rate (2012-2017)
11.6.2 Global Price (2012-2017)

12 Global Circulating Tumor Cells by Application
12.1 Global Circulating Tumor Cells Sales Market Share by Application (2012-2017)
12.2 Prostate Cancer Sales Growth Rate (2012-2017)
12.3 Breast Cancer Sales Growth Rate (2012-2017)
12.4 Colorectal Cancer Sales Growth Rate (2012-2017)
12.5 Others Sales Growth Rate (2012-2017)
12.6 Sales Growth Rate (2012-2017)

13 Global Circulating Tumor Cells Market Forecast (2018-2023)
13.1 Global Circulating Tumor Cells Sales Volume, Revenue and Price Forecast (2018-2023)
13.1.1 Global Circulating Tumor Cells Sales Volume and Growth Rate Forecast (2018-2023)
13.1.2 Global Circulating Tumor Cells Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Global Circulating Tumor Cells Price and Trend Forecast (2018-2023)
13.2 Global Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Global Circulating Tumor Cells Sales Volume and Growth Rate Forecast by Regions (2018-2023)
13.2.2 Global Circulating Tumor Cells Revenue and Growth Rate Forecast by Regions (2018-2023)
13.2.3 Global Circulating Tumor Cells market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 North America (United States, Canada and Mexico) Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 South America (Brazil, Argentina, Columbia) Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.3 Global Circulating Tumor Cells Sales Volume, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Global Circulating Tumor Cells Sales Forecast by Type (2018-2023)
13.3.2 Global Circulating Tumor Cells Revenue Forecast by Type (2018-2023)
13.3.3 Global Circulating Tumor Cells Price Forecast by Type (2018-2023)
13.4 Global Circulating Tumor Cells Sales Volume Forecast by Application (2018-2023)
13.4.1 Global Circulating Tumor Cells Sales Forecast by Application (2018-2023)
13.4.2 Global Circulating Tumor Cells Market Share Forecast by Application (2018-2023)

14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.2 Analyst Introduction
16.3 Data Source